Legal Representation
Attorney
BRUCE W LONGBOTTOM
USPTO Deadlines
Application History
23 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jul 11, 2007 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Jul 11, 2007 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
| Aug 31, 2006 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Aug 31, 2006 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| Aug 31, 2006 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| Apr 15, 2006 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Mar 27, 2006 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Mar 27, 2006 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Sep 12, 2005 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Sep 2, 2005 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Sep 2, 2005 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Mar 8, 2005 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Feb 17, 2005 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Feb 17, 2005 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Sep 10, 2004 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Sep 10, 2004 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Sep 10, 2004 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Apr 27, 2004 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Feb 3, 2004 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jan 14, 2004 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| Nov 19, 2003 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Nov 13, 2003 | CNEA | F | EXAMINER'S AMENDMENT MAILED | Loading... |
| Nov 1, 2003 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Detailed Classifications
Class 005
pharmaceutical and medicinal preparations for the treatment and prevention of blood disorders, cancer and oncological disease, cardiovascular diseases, central nervous systems diseases and disorders, dermatological disorders, diabetes, diabetic neuropathy, endocrine disorders, gastrointestinal disorders, hormonal diseases and disorders, immunological, bacterial, viral and fungal disorders, infectious diseases, inflammation and inflammatory diseases, macular degeneration, musculoskeletal disorders, neurodegenerative disorders, neurological disorders, obesity, ophthalmologic conditions and diseases, pain, peripheral nervous system diseases and disorders, reproductive disorders, sexual dysfunction, sepsis, and urological disorders
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005